| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.32 | 0.08 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.05 | 0.08 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.057 | 0.08 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.08 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.052 | 0.08 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.054 | 0.08 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.09 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.062 | 0.09 |